DEXCOM INC — Director's Dealing 2020

Nov 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-11-19

Reporting Person: Regan Barry J. (EVP Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-19	Common Stock	A	8207	$0.001	Acquired	8207	Direct

Footnotes

F1: Represents a grant of RSUs that vest in four annual installments on November 19, 2021, November 19, 2022, November 19, 2023 and November 19, 2024. Share units
represent a contingent right to receive one share of Dexcom, Inc. common stock upon settlement for no consideration.